Cost–effectiveness analysis of serplulimab as first-line treatment for advanced esophageal squamous cell carcinoma
Article in Immunotherapy (July 2023)
The most recent citing publication is shown below. View this citation on Dimensions.
Article in Immunotherapy (July 2023)